Hengyu Biotech Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 150

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $27.9M

  • Investors
  • 10

Hengyu Biotech General Information

Description

Provider of biological testing services for drug developers. The company is committed to providing complete biosafety testing solutions for global innovative pharmaceutical companies, offering services such as viral clearance process validation, cell bank validation, replicative virus testing (RCL, RCR, rcAAV, RCA), batch release testing, CGT bioanalysis, and process residue testing to meet the filing requirements of the United States, China, and Europe, covering the entire life cycle of biologics from R&D to marketing.

Contact Information

Website
www.hengyudetc.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 41, Liandong U Valley
  • No. 168 Qiantangjiang Road, Jiashan County Economic Development Zone
  • Jiaxing, Zhejiang
  • China
+86 0573
Primary Industry
Laboratory Services (Healthcare)
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • Building 41, Liandong U Valley
  • No. 168 Qiantangjiang Road, Jiashan County Economic Development Zone
  • Jiaxing, Zhejiang
  • China
+86 0573

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hengyu Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 11-Mar-2024 $27.9M Completed Generating Revenue
3. Early Stage VC (Series A1) 25-Jul-2022 Completed Generating Revenue
2. Early Stage VC (Series A) 06-Aug-2021 $9.3M $9.3M Completed Generating Revenue
1. Seed Round 01-Jan-2021 Completed Startup
To view Hengyu Biotech’s complete valuation and funding history, request access »

Hengyu Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hengyu Biotech Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
CMB International Capital Asset Manager Minority
Hangzhou Hongcheng Capital Growth/Expansion Minority
Heda Ventures Venture Capital Minority
Zhejiang Kunxin Investment Management Growth/Expansion Minority
HaiBang Ventures Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Hengyu Biotech FAQs

  • When was Hengyu Biotech founded?

    Hengyu Biotech was founded in 2020.

  • Where is Hengyu Biotech headquartered?

    Hengyu Biotech is headquartered in Jiaxing, China.

  • What is the size of Hengyu Biotech?

    Hengyu Biotech has 150 total employees.

  • What industry is Hengyu Biotech in?

    Hengyu Biotech’s primary industry is Laboratory Services (Healthcare).

  • Is Hengyu Biotech a private or public company?

    Hengyu Biotech is a Private company.

  • What is Hengyu Biotech’s current revenue?

    The current revenue for Hengyu Biotech is .

  • How much funding has Hengyu Biotech raised over time?

    Hengyu Biotech has raised $37.1M.

  • Who are Hengyu Biotech’s investors?

    CMB International Capital, Hangzhou Hongcheng Capital, Heda Ventures, Zhejiang Kunxin Investment Management, and HaiBang Ventures are 5 of 10 investors who have invested in Hengyu Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process